MarketPeel
Insider Trading Intelligence
Pricing
…
SM

Sandeep Menon

BCRX
CHIEF R&D OFFICER · BIOCRYST PHARMACEUTICALS INC · CIK 0002123967
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
441,350
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Sandeep Menon. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
BCRX · 441,350 shares · as of Apr 6, 2026
0110,338220,675331,013441,350SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
205,150——205,150Apr 6, 2026Apr 7, 2026 ↗
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
441,350——441,350Apr 6, 2026Apr 7, 2026 ↗
Other insiders · BCRX
Loading peer insiders…
About this filer
CIK 0002123967
ROLE
Chief R&D Officer
PRIMARY
BCRX
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0002123967DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback